New pages

04:3404:34, 22 December 2014 Afghanistan (hist | edit) [6,611 bytes] LMyhre (talk | contribs) (New page: '''Score = ##''' ''Governed by:'' Competition Law<ref>Competition Promotion and Consumer Protection Directorate(CPCPD), http://www.cpcpd.gov.af/the-law.html</ref>. The 2010 law is not cur...)

18:4518:45, 8 June 2012 Industry Standard Setting and Antitrust (hist | edit) [81,977 bytes] LMyhre (talk | contribs) (New page: Author: Tzu-Yuan Lin Date: 2009 == Abstract == Since the standard setting organizations (SSOs) began to permit patents to be incorporated into standards, the relationship between sta...)

19:3419:34, 27 June 2011 American Legal Perspectives on China’s Landmark Anti-Monopoly Rulings (hist | edit) [63,042 bytes] LMyhre (talk | contribs) (New page: Author: Mick Bordonaro Date: May 25, 2011 Introduction In late 2008 and early 2009, the Chinese Ministry of Commerce’s Anti-Monopoly Bureau released two landmark decisions.<ref> Yingb...)
19:3319:33, 27 June 2011 EU Competition Law Enforcement: The Pharma Sector Inquiry (hist | edit) [42,242 bytes] LMyhre (talk | contribs) (New page: Author: Lynne Myhre Date: June 2009 == Introduction == While antitrust laws in the European Union and the United States are similar, the rationale for enforcement of those laws, a...)

20:2820:28, 18 June 2011 The European Union’s Pharmaceutical Sector Inquiry: Competition Law in the European Union (hist | edit) [42,218 bytes] LMyhre (talk | contribs) (New page: == Introduction == While antitrust laws in the European Union and the United States are similar, the rationale for enforcement of those laws, and the mechanisms for their enforcement, ca...)
20:1320:13, 18 June 2011 EU Competition Law Enforcement: Pharmaceutical Sector Inquiry (hist | edit) [42,174 bytes] LMyhre (talk | contribs) (The recent European Union inquiry into the pharmaceutical sector’s business practices provides a lens for examining how competition law operates in the EU.)

Navigation menu